Showing results (61-70 of 209) with videos related to
Sort By:
Pageof 21
The American Journal of Gastroenterology|September 1, 1995
Collagenous and lymphocytic colitis: subject review and therapeutic alternativesB J Zins, W J Sandborn, W J TremaineThe American Journal of Gastroenterology|January 1, 1996
Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporineW J Sandborn, W J Tremaine, G M LawsonAlimentary Pharmacology & Therapeutics|February 16, 2005
Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trialS Hanauer, W J Sandborn, A Persson, et al.Alimentary Pharmacology & Therapeutics|September 20, 2007
Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remissionW J Sandborn, B G Feagan, G R LichtensteinThe American Journal of Gastroenterology|March 28, 1998
Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporineL J Egan, W J Sandborn, W J TremaineAnnals of Internal Medicine|November 20, 2001
Diagnosis and treatment of perianal fistulas in Crohn diseaseD A Schwartz, J H Pemberton, W J SandbornJournal of Clinical Gastroenterology|December 1, 1994
Cytomegalovirus as an exacerbating factor in ulcerative colitisE V Loftus, G L Alexander, H A CarpenterSurgical Endoscopy|September 1, 2005
Total laparoscopic proctocolectomy with Brooke ileostomy: a novel incisionless surgical treatment for patients with ulcerative colitisD W Larson, E Dozois, W J Sandborn, et al.Alimentary Pharmacology & Therapeutics|June 20, 2018
Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn's diseaseS Singh, M Fumery, W J Sandborn, et al.Journal of Crohn'S & Colitis|February 18, 2015
Introducing vedolizumab to clinical practice: who, when, and how?R V Bryant, W J Sandborn, S P L TravisPageof 21